Animal models for arthritis: innovative tools for prevention and treatment
- PMID: 21628308
- DOI: 10.1136/ard.2010.148551
Animal models for arthritis: innovative tools for prevention and treatment
Abstract
The development of novel treatments for rheumatoid arthritis (RA) requires the interplay between clinical observations and studies in animal models. Given the complex molecular pathogenesis and highly heterogeneous clinical picture of RA, there is an urgent need to dissect its multifactorial nature and to propose new strategies for preventive, early and curative treatments. Research on animal models has generated new knowledge on RA pathophysiology and aetiology and has provided highly successful paradigms for innovative drug development. Recent focus has shifted towards the discovery of novel biomarkers, with emphasis on presymptomatic and emerging stages of human RA, and towards addressing the pathophysiological mechanisms and subsequent efficacy of interventions that underlie different disease variants. Shifts in the current paradigms underlying RA pathogenesis have also led to increased demand for new (including humanised) animal models. There is therefore an urgent need to integrate the knowledge on human and animal models with the ultimate goal of creating a comprehensive 'pathogenesis map' that will guide alignment of existing and new animal models to the subset of disease they mimic. This requires full and standardised characterisation of all models at the genotypic, phenotypic and biomarker level, exploiting recent technological developments in 'omics' profiling and computational biology as well as state of the art bioimaging. Efficient integration and dissemination of information and resources as well as outreach to the public will be necessary to manage the plethora of data accumulated and to increase community awareness and support for innovative animal model research in rheumatology.
Similar articles
-
Possibilities for preventive treatment in rheumatoid arthritis? Lessons from experimental animal models of arthritis: a systematic literature review and meta-analysis.Ann Rheum Dis. 2017 Feb;76(2):458-467. doi: 10.1136/annrheumdis-2016-209830. Epub 2016 Aug 1. Ann Rheum Dis. 2017. PMID: 27481831 Review.
-
Rheumatoid arthritis research in the 21st century: Limitations of traditional models, new technologies, and opportunities for a human biology-based approach.ALTEX. 2020;37(2):223-242. doi: 10.14573/altex.1910011. Epub 2019 Dec 17. ALTEX. 2020. PMID: 31854453 Review.
-
Utility of animal models for identification of potential therapeutics for rheumatoid arthritis.Ann Rheum Dis. 2008 Nov;67(11):1505-15. doi: 10.1136/ard.2007.076430. Epub 2007 Nov 29. Ann Rheum Dis. 2008. PMID: 18055474 Review.
-
Is the prevention of rheumatoid arthritis possible?Clin Rheumatol. 2020 May;39(5):1383-1389. doi: 10.1007/s10067-020-04927-6. Epub 2020 Feb 3. Clin Rheumatol. 2020. PMID: 32016656 Review.
-
New drug discovery strategies for rheumatoid arthritis: a niche for nonhuman primate models to address systemic complications in inflammatory arthritis.Expert Opin Drug Discov. 2012 Apr;7(4):315-25. doi: 10.1517/17460441.2012.666523. Epub 2012 Feb 28. Expert Opin Drug Discov. 2012. PMID: 22458503 Review.
Cited by
-
Human adipose-derived mesenchymal stem cells attenuate collagen antibody-induced autoimmune arthritis by inducing expression of FCGIIB receptors.BMC Musculoskelet Disord. 2015 Jul 27;16:170. doi: 10.1186/s12891-015-0634-y. BMC Musculoskelet Disord. 2015. PMID: 26210906 Free PMC article.
-
Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis.J Exp Med. 2012 May 7;209(5):925-33. doi: 10.1084/jem.20112012. Epub 2012 Apr 9. J Exp Med. 2012. PMID: 22493518 Free PMC article.
-
Statins accelerate the onset of collagen type II-induced arthritis in mice.Arthritis Res Ther. 2012 Apr 26;14(2):R90. doi: 10.1186/ar3814. Arthritis Res Ther. 2012. PMID: 22537858 Free PMC article.
-
ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts.Nat Immunol. 2022 Sep;23(9):1330-1341. doi: 10.1038/s41590-022-01285-0. Epub 2022 Aug 23. Nat Immunol. 2022. PMID: 35999392
-
WTD Attenuating Rheumatoid Arthritis via Suppressing Angiogenesis and Modulating the PI3K/AKT/mTOR/HIF-1α Pathway.Front Pharmacol. 2021 Sep 27;12:696802. doi: 10.3389/fphar.2021.696802. eCollection 2021. Front Pharmacol. 2021. PMID: 34646130 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical